Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Will the UK’s ambitious life sciences investment power-up the psychedelic sector? Read More Opinion Arda Ozcubukcu 09/01/2023 Opinion Arda Ozcubukcu 09/01/2023 Transatlantic Psychedelics: drug developers without borders Read More Opinion Arda Ozcubukcu 21/11/2022 Opinion Arda Ozcubukcu 21/11/2022 The Weakest Link: Poor quality therapists a risk to psychedelic trial success Read More Opinion Arda Ozcubukcu 27/10/2022 Opinion Arda Ozcubukcu 27/10/2022 Regulatory approval in under 8 weeks possible for psychedelic trials in the UK Read More Opinion Arda Ozcubukcu 29/09/2022 Opinion Arda Ozcubukcu 29/09/2022 Rising tides lift all ships: What attracts drug developers to the UK’s psychedelic ecosystem? Read More Opinion Arda Ozcubukcu 14/07/2022 Opinion Arda Ozcubukcu 14/07/2022 The Race for Data Exclusivity Read More Opinion Clerkenwell Press Office 21/06/2022 Opinion Clerkenwell Press Office 21/06/2022 How It Works: ‘Setting’ Read More Announcement Clerkenwell Press Office 26/05/2022 Announcement Clerkenwell Press Office 26/05/2022 Clerkenwell Health Taps Top Academics and Expands Pan-European Scientific Advisory Board Read More Announcement Clerkenwell Press Office 12/05/2022 Announcement Clerkenwell Press Office 12/05/2022 Why we’re opening Europe’s first commercial psychedelic research facility Read More Opinion Arda Ozcubukcu 31/03/2022 Opinion Arda Ozcubukcu 31/03/2022 Thou Shalt Not Pass: Solving the Psychedelic Specialist Therapist Bottleneck Read More Opinion Arda Ozcubukcu 22/11/2021 Opinion Arda Ozcubukcu 22/11/2021 Is the UK an ideal location to run psychedelic trials? Read More Opinion Arda Ozcubukcu 21/09/2021 Opinion Arda Ozcubukcu 21/09/2021 Why Psychedelic Drugs Need Specialist Clinical Research Organisations? Read More Announcement Clerkenwell Press Office 08/09/2021 Announcement Clerkenwell Press Office 08/09/2021 Danish and British Psychedelic Startups Partner to Bring Innovative Psychedelics to Patients Read More
Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Will the UK’s ambitious life sciences investment power-up the psychedelic sector? Read More
Opinion Arda Ozcubukcu 09/01/2023 Opinion Arda Ozcubukcu 09/01/2023 Transatlantic Psychedelics: drug developers without borders Read More
Opinion Arda Ozcubukcu 21/11/2022 Opinion Arda Ozcubukcu 21/11/2022 The Weakest Link: Poor quality therapists a risk to psychedelic trial success Read More
Opinion Arda Ozcubukcu 27/10/2022 Opinion Arda Ozcubukcu 27/10/2022 Regulatory approval in under 8 weeks possible for psychedelic trials in the UK Read More
Opinion Arda Ozcubukcu 29/09/2022 Opinion Arda Ozcubukcu 29/09/2022 Rising tides lift all ships: What attracts drug developers to the UK’s psychedelic ecosystem? Read More
Opinion Arda Ozcubukcu 14/07/2022 Opinion Arda Ozcubukcu 14/07/2022 The Race for Data Exclusivity Read More
Opinion Clerkenwell Press Office 21/06/2022 Opinion Clerkenwell Press Office 21/06/2022 How It Works: ‘Setting’ Read More
Announcement Clerkenwell Press Office 26/05/2022 Announcement Clerkenwell Press Office 26/05/2022 Clerkenwell Health Taps Top Academics and Expands Pan-European Scientific Advisory Board Read More
Announcement Clerkenwell Press Office 12/05/2022 Announcement Clerkenwell Press Office 12/05/2022 Why we’re opening Europe’s first commercial psychedelic research facility Read More
Opinion Arda Ozcubukcu 31/03/2022 Opinion Arda Ozcubukcu 31/03/2022 Thou Shalt Not Pass: Solving the Psychedelic Specialist Therapist Bottleneck Read More
Opinion Arda Ozcubukcu 22/11/2021 Opinion Arda Ozcubukcu 22/11/2021 Is the UK an ideal location to run psychedelic trials? Read More
Opinion Arda Ozcubukcu 21/09/2021 Opinion Arda Ozcubukcu 21/09/2021 Why Psychedelic Drugs Need Specialist Clinical Research Organisations? Read More
Announcement Clerkenwell Press Office 08/09/2021 Announcement Clerkenwell Press Office 08/09/2021 Danish and British Psychedelic Startups Partner to Bring Innovative Psychedelics to Patients Read More